NCT00263952CompletedPhase 3
Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies.
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Allergopharma GmbH & Co. KG
- Locations
- 2
Study Overview
Brief Summary
The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •History of bee venom allergy,
- •Positive RAST for bee venom,
- •Positive skin prick test for bee venom
Exclusion Criteria
- •Serious chronic diseases
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Phase 3
Efficacy and Safety of a Purified Standardised Wasp Venom PreparationAllergyNCT00263926Allergopharma GmbH & Co. KG
Terminated
Phase 1
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch PollenAllergic RhinitisAllergyNCT01728519Anergis29
Recruiting
Not Applicable
Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy FailureBee Venom AllergyNCT04259359Medical University of Graz266
Unknown
Phase 3
Safety and Efficacy Study of Bee Venom to Treat Knee OsteoarthritisPersons With Mild to Moderate Knee OsteoarthritisNCT00253942Rheumatology Therapeutics Medical Center40
Unknown
Phase 2
Bee Venom Acupuncture for the Treatment of Chronic Low Back PainChronic Low Back PainNCT01491321Kyunghee University Medical Center54